Table 1.
Protein-based biomimetic materials and current application status.
Materials | Applications | Cell types and animals | Research approaches | Ref. |
---|---|---|---|---|
Phospholipids and membrane proteins from leukocytes | Treatment and Diagnosis | Murine 4T1 cells; male apolipoprotein E (ApoE) –/– mice; Female BALB/c mice | In vivo | [14] |
GST | Tumor imaging | E. coli BL21 (DE3) cells; Hela cells; C57BL\6 mice; female Balb/c mice | In vivo and in vitro | [15] |
BSA | Diagnosis | MCF-7 cells | In vivo and in vitro | [8] |
BSA | Diagnosis | MGC803 gastric cells | In vitro | [17] |
rHDL | Treatment | HepG2 cells; MCF-7 cells; Female BALB/c nude mice | In vivo and in vitro | [18] |
Albumin | Treatment | U87 cells; C6, GL216, and U251 cells; Luc-U87 cells; U87 orthotopic glioma mice; | In vivo and in vitro | [19] |
GroEL | Treatment | MDA-MB-231; Panc-1; HPNE and 293T; BALB/c nude mice | In vivo and in vitro | [22] |
Silk protein | Drug delivery | Human skin fibroblast (ATCC CRL-2522) and colorectal adenocarcinoma (Caco-2; ATCC HTB-37) cells | In vitro | [72] |
AXT050 | Drug delivery | MDA-MB-231 cells and microvascular endothelial cell (MEC) cells | In vivo and in vitro | [73] |